Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Schott Pharma AG & Co. Kgaa Stock

Price
Target price
€13.78

€13.78

-0.580%
-0.08
-0.580%
-

-

 
Buy 4 Sell 0
Buy 4
Sell 0
19:09 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Latest predictions
13.02.26
-7.39%
buy
12.02.26
-7.52%
buy
14.08.25
-41.11%
buy
06.06.25
-50.61%
buy
Show more
Your prediction
Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years
Wizard

Schott Pharma AG & Co. Kgaa Stock

Schott Pharma AG & Co. Kgaa shows a slight decrease today, losing -€0.080 (-0.580%) compared to yesterday.
What does Schott Pharma & Co. Kgaa do?

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice
Register To Post

News

EQS-News: SCHOTT Pharma delivers on full-year revenue and profitability targets
EQS-News: SCHOTT Pharma delivers on full-year revenue and profitability targets
EQS-News: SCHOTT Pharma delivers on full-year revenue and profitability targets
eqs_en 
0 11.12.25
EQS-News: SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
EQS-News: SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
EQS-News: SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
eqs_en 
0 04.12.25
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance
eqs_en 
0 04.12.25